LobbyingIgm Biosciences lobbying by quarter
Igm Biosciences's latest lobbying report covers Q4 2024, at $15K. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs and Defense.
Igm Biosciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $220K | 2 |
| Q1 2023 | $250K | 2 |
| Q2 2023 | $240K | 2 |
| Q3 2023 | $240K | 2 |
| Q4 2023 | $250K | 2 |
| Q1 2024 | $120K | 2 |
| Q2 2024 | $80K | 2 |
| Q3 2024 | $70K | 2 |
| Q4 2024 | $15K | 2 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$1.4M · 8 reports
- Defense$95K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES16 reports
- SENATE16 reports
- Health & Human Services, Dept of (HHS)5 reports
- Executive Office of the President (EOP)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseIgm Biosciences | $1.4M | 9 quarters |
| Strategic Marketing Innovations | $95K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| WILLIAM MCCANN | Chief of Staff, Legislative Director, Rep. Marty Meehan | Q4 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/01/21for Q4 2024 | In-house | $10K |
| 25/01/14for Q4 2024 | Strategic Marketing Innovations | $5,000 |
| 24/10/21for Q3 2024 | In-house | $50K |
| 24/10/16for Q3 2024 | Strategic Marketing Innovations | $20K |
| 24/07/22for Q2 2024 | In-house | $80K |
| 24/07/22for Q2 2024 | Strategic Marketing Innovations | Under $5,000 |
| 24/07/18for Q2 2024 | Strategic Marketing Innovations | $15K |
| 24/04/22for Q1 2024 | In-house | $110K |
| 24/04/21for Q1 2024 | Strategic Marketing Innovations | $10K |
| 24/01/21for Q4 2023 | Strategic Marketing Innovations | $10K |
| 24/01/19for Q4 2023 | In-house | $240K |
| 23/10/20for Q3 2023 | In-house | $230K |
| 23/10/19for Q3 2023 | Strategic Marketing Innovations | $10K |
| 23/07/17for Q2 2023 | In-house | $230K |
| 23/07/13for Q2 2023 | Strategic Marketing Innovations | $10K |
| 23/04/20for Q1 2023 | Strategic Marketing Innovations | $20K |
| 23/04/20for Q1 2023 | In-house | $230K |
| 23/01/20for Q4 2022 | In-house | $210K |
| 23/01/20for Q4 2022 | Strategic Marketing Innovations | $10K |